AGEN1307 is a human monoclonal antibody (mAb) targeting TIGIT. It features an active FcgammaR binding region, enhancing antibody-dependent cellular cytotoxicity (ADCC). AGEN1307 is utilized in cancer research.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
